1. Home
  2. GBIO vs BGSF Comparison

GBIO vs BGSF Comparison

Compare GBIO & BGSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • BGSF
  • Stock Information
  • Founded
  • GBIO 2016
  • BGSF 2007
  • Country
  • GBIO United States
  • BGSF United States
  • Employees
  • GBIO N/A
  • BGSF N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • BGSF Professional Services
  • Sector
  • GBIO Health Care
  • BGSF Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • BGSF Nasdaq
  • Market Cap
  • GBIO 64.8M
  • BGSF 66.0M
  • IPO Year
  • GBIO 2020
  • BGSF N/A
  • Fundamental
  • Price
  • GBIO $0.78
  • BGSF $5.22
  • Analyst Decision
  • GBIO Strong Buy
  • BGSF
  • Analyst Count
  • GBIO 2
  • BGSF 0
  • Target Price
  • GBIO $6.50
  • BGSF N/A
  • AVG Volume (30 Days)
  • GBIO 649.2K
  • BGSF 12.7K
  • Earning Date
  • GBIO 03-05-2025
  • BGSF 03-12-2025
  • Dividend Yield
  • GBIO N/A
  • BGSF 2.90%
  • EPS Growth
  • GBIO N/A
  • BGSF N/A
  • EPS
  • GBIO N/A
  • BGSF N/A
  • Revenue
  • GBIO $18,582,000.00
  • BGSF $281,656,000.00
  • Revenue This Year
  • GBIO $212.74
  • BGSF N/A
  • Revenue Next Year
  • GBIO N/A
  • BGSF $5.63
  • P/E Ratio
  • GBIO N/A
  • BGSF N/A
  • Revenue Growth
  • GBIO 514.08
  • BGSF N/A
  • 52 Week Low
  • GBIO $0.72
  • BGSF $5.03
  • 52 Week High
  • GBIO $4.65
  • BGSF $10.50
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 29.26
  • BGSF 43.17
  • Support Level
  • GBIO $0.72
  • BGSF $5.07
  • Resistance Level
  • GBIO $1.00
  • BGSF $5.37
  • Average True Range (ATR)
  • GBIO 0.07
  • BGSF 0.19
  • MACD
  • GBIO -0.00
  • BGSF 0.03
  • Stochastic Oscillator
  • GBIO 18.68
  • BGSF 36.54

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About BGSF BGSF Inc.

BGSF Inc is a provider of workforce solutions operating primarily in the U.S. across two segments: Property Management and Professional. In the Property Management segment, BGSF offers office and maintenance talent to clients, facilitating their staffing needs with short-term and consulting solutions. The Professional segment specializes in IT, offering skilled professionals in SAP, Workday, and other areas to Fortune 500 companies and consulting firms nationwide. BGSF's workforce services include on-demand assignments, consulting, and managed solutions, allowing clients to flexibly manage their workforce needs. With a focus on converting fixed personnel costs to variable expenses, BGSF enables companies to effectively address fluctuations in demand while optimizing costs.

Share on Social Networks: